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Purpose: To determine the prevalence and genetic basis of tetracycline resistance in Staphylococcus 
aureus. 
Methods: One hundred and thirty (130) clinical isolates of S. aureus were collected from Khyber Teaching 
Hospital, Peshawar, Pakistan. Susceptibility to antibiotics (doxycycline, tetracycline and minocycline) was 
determined by Kirby-Bauer disc diffusion method with minimum inhibitory concentration (MIC) evaluated on 
Muller-Hinton agar as described by the Clinical and Laboratory Standards Institute (CLSI). The tetracycline-
resistant strains (TET-R) were screened by polymerase chain reaction (PCR) for the presence of four common 
tetracycline resistance determinants, viz, tet(K), tet(L), tet(M) and tet(O). 
Results: Sixty (46.0 %) of these isolates were methicillin-resistant S. aureus (MRSA) while 70 (54.0 %) 
were methicillin-susceptible S. aureus (MSSA). Seventy four (56.9 %) strains were resistant to 
tetracycline (TET-R), 30 (23.1 %) to minocycline and 23 (17.7 %) to doxycycline. A majority of the 
MRSA were resistant to tetracyclines and all the MSSA were sensitive to doxycycline and minocycline. 
The tet(K) gene was found in 58 isolates and tet(L) in one isolate. No tet(M) and tet(O) were detected.  
Conclusion: This study indicates that resistance to tetracyclines is mainly by efflux pumps mediated by 
tet(K) in S. aureus in northwestern Pakistan. 
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INTRODUCTION 
 
Tetracyclines are broad spectrum antibiotics 
used against a wide variety of bacterial 
infections, including both Gram-positive and 
Gram-negative. After their discovery in the 
1940’s, tetracyclines have continuously been 
used in both humans and animals with no 
major adverse effects. Tetracyclines inhibit 
bacterial ribosome from associating with the 
aminoacyl-tRNA and as a result, protein 
synthesis is inhibited. The discovery of 
tetracyclines sparked the development of 
many chemically altered antibiotics: including 
semisynthetic drugs such as minocycline and 
doxycycline [1].  
 
A large number of tetracycline resistance 
genes have been identified. There are 38 
acquired tetracycline resistance genes that 
are known and all use one of three strategies 
to render the bacteria resistant [2]. These 
include (1) efflux proteins, (2) ribosomal 
protection proteins and (3) enzymatic 
inactivation of tetracycline.  
 
The majority of these genes (60 %) code for 
energy-dependent efflux pumps, and different 
bacterial genera tend to have the same efflux 
or ribosomal protection genes [3]. This 
indicates that tetracycline resistance genes 
can be transferred amongst the bacterial 
population. In fact, resistance to tetracycline 
in most bacteria is due to the acquisition of 
new genes; these genes tend to be 
associated with mobile elements such as 
transposons and plasmids [1]. Acne patients 
often require sequential treatment with 
tetracycline with several courses, which can 
last from three months to several years [4]. 
This long-term antibiotic treatment exerts a 
long selective pressure on both the targeted 
propionibacteria and the other microflora of 
the skin.  
 
Tetacycline resistance genes: tetK, tetM, tetO 
and tetL are four major genes associated with 
tetracycline resistance amongst Gram-
positive bacteria. The tetK and tetL genes 
code for efflux proteins; these are energy-
dependent membrane-associated proteins 
which prevent tetracycline from accumulating 
within the cell [3]. The other two genes, tetM 
and tetO, code for ribosomal protection 
proteins, which reduce the affinity of 
tetracycline to the ribosome [5]. 
 
Surveillance for detection of various tet 
determinants has been carried out worldwide. 
In 2006, Jones et al found 74.0 % tetK and 
13.0 % tetM in MRSA, and 73.8 % tetK and 
21.4 % tetM in MSSA in a worldwide 
collection of S. aureus [6]. A study conducted 
by the SENTRY Antimicrobial Surveillance 
Programme between 1997 and 1999 found 
57.0 and 10.0 % resistance to tetracycline in 
MRSA and MSSA, respectively. They 
recorded high prevalence of tetM in MRSA 
(76.0 %) and of tetK in MSSA (96.0 %) [7].  
 
Tetracyclines are extensively used in 
Pakistan for skin and throat infections. But 
little surveillance work has been done to 
assess the extent of resistance. The aim of 
this study was to determine the genetic basis 
of tetracycline resistance in S. aureus. This is 
the first report disclosing genetic basis of 







Between April 2005 and May 2006, 130 non-
duplicate, consecutive S. aureus isolates 
were collected from in- and out-patients at 
Khyber Teaching Hospital, a tertiary care 
hospital in Peshawar. In this study, 130 S. 
aureus were obtained from various sources. 
There were 69 male and 61 female patients.  
A majority of the isolates were obtained from 
wound and burn/skin infections. Identification 
was carried out by Gram stain, catalase, 
coagulase and DNAse tests. 
 
Antimicrobial agents susceptibility testing 
 
Susceptibility to antimicrobial agents was 
determined by Kirby-Bauer disc diffusion and 
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minimum inhibitory concentration (MIC) 
method on Muller-Hinton agar (Oxoid, 
England) as per Clinical and Laboratory 
Standards Institute (CLSI) guidelines [8]. The 
tetracycline antibiotics used against the 
collected strains were: doxycycline (DOX), 
tetracycline (TET), and minocycline (MN). E. 
coli NCTC 10418 was used as control for 
susceptibility testing.  
 
Bacterial DNA extraction 
 
Achromopeptidase method was used for 
DNA extraction. In this method, 50 ul of NaCl-
EDTA Tris (NET) buffer (1x TE buffer in PCR 
water plus 20ul 5M NaCl) was added to 10 ml 
achromopeptidase solution in a small tube. 
Thereafter, 2 - 3 fresh colonies (18 – 20 h) of 
S. aureus were added and incubated for 15 - 
20 min at 50 oC. After incubation, the 
extracted DNA was diluted 10 times in NET 
buffer for molecular work. The DNA was 
stored at –4o C and used for up to one 
month.  
 
Confirmation of MRSA 
 
The phenotypically identified MRSA, using 30 
µg cefoxitn disc, were genotypically 
confirmed by a duplex PCR targeting mecA 
gene responsible for methicillin resistance 
and a specific region of 16s rDNA region of 
the S. aureus (nuc gene). The primers used 
are stated in Table 1. 
 
Determination of tetracycline resistance 
genes using PCR 
 
The presence of tetK, tetM, tetL and tetO 
genes responsible for tetracycline resistance 
was detected by PCR. The primer sequence, 
amplicon size and reference for the detection 
of each gene are given in Table 1.  
 
Agarose gel electrophoresis 
 
The amplified products were run on 1.5 % 
agarose gel in Tris-Acetate EDTA (TAE) 
buffer for 45 min. The ethidium bromide 
stained bands were examined under an 
ultraviolet transilluminator and photographed 




Statistical analysis was performed by Chi-
square test (Minitab 15 software) and p- 
values of ≤ 0.05 were considered significant. 
 
Table 1: PCR primer sequences, amplicon size and PCR conditions 
 
Gene 
targeted Primer sequence (5-3) 
Amplicon 
size (bp) Reference PCR conditions 






1 cycle of  950 for 5 min      
30 cycles of 950C for 30 s 
  550C for 30 se 
  720C for 1 min      
1 cycle of 720C for 5 min    




R-AACCAGCCAACTAATGACAAGAT 1077 [12] 
tet(M) F-AGTTTTAGCTCATGTTGATG R-TCCGACTATTTAGACGACGG  1862 [12] 
1 cycle of  950 for 5 min      
 
30 cycles of 950C for 60 s 
  550C for 60 s 
  720C for 90 s      
1 cycle of 720C for 5 min    
tet(O) F-AACTTAGGCATTCTGGCTCAC R-TCCCACTGTTCCATATCGTCA 515 [13] 
1 cycle of  940 for 5 min      
30 cycles of 94 0C for 60 s 
  500C for 60 s s 
  720C for 90 s     
1 cycle of 720C for 5 min    
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RESULTS 
 
The age range of the patients was 3 months 
to 80 years with a mean of 28 years. There 
were 60 (46.15%) isolates that were resistant 
to cefoxitin, i.e., were MRSA (methicillin 
resistant S. aureus). These MRSA strains 
were also confirmed by PCR. Among the 
tetracycline antibiotics tested, 98 (75.4 %) 
isolates were susceptible to minocycline, 79 
(60.8 %) to doxycycline and 55 (42.3 %) to 
tetracycline. A significant difference was 
found in the susceptibilities of all the 
tetracyclines used (p < 0.05). Among MRSA, 
30 strains (50.0 %) were resistant to 
minocycline, 23 (38.3 %) to doxycycline and 
48 (80.0 %) to tetracycline. All the MSSA 
strains were sensitive to minocycline and 
doxycycline, while 26 (37.1 %) were resistant 
to tetracycline (Table 2). 
 
On screening the 74 isolates resistant to 
tetracycline for the presence of tetK, tetO, 
tetM and tetL genes, tetK gene was found in 
58 isolates, made up of 34 among MRSA and 
24 among MSSA. The electrophoretic gel 
photo for tetK is given in Figure 1. Only one 
tetL gene was found in MRSA. No tetM and 
tetO genes were found in these isolates. 
 
All the tetK positive strains were highly 
resistant to tetracycline, MIC50 being 64ml/ml. 
The MIC distribution curve is shown in Figure 
2. Among tetK positive S. aureus, 40 (67.8 
%) were susceptible to doxycycline and 19 




This study was conducted to identify the 
molecular mechanisms of resistance against 
tetracycline by S. aureus in Pakistan. The 
results of tetracyclines susceptibility in this 
study are in agreement with those of others 
who observed 83 and > 50 % resistance to 
tetracycline, respectively. [14,15].  
 
Table 2: Susceptibility of the total isolated S. aureus and comparison of susceptibility between 
MRSA and MSSA to tetracyclines  
 













Minocycline 98 (75.38) 02 (01.54) 30 (23.08) 2 64 
Doxycycline 79 (60.77) 28 (21.54) 23 (17.69) 4 16 
Tetracycline 55 (42.31) 1 (0.77) 74 (56.92) 16 64 
 MRSA n=60 
Minocycline 28 (46.67) 2 (00.33) 30 (50.00) 8 64 
Doxycycline 18 (30.00) 19 (31.67) 23 (38.33) 8 16 
Tetracycline 12 (20.00) 0 (0.00) 48 (80.00) 64 128 
 MSSA n=70 
Minocycline 70 (100) 0 (0.00) 0 (0.00) 2 4 
Doxycycline 61 (87.14) 9 (12.86) 0 (0.00) 0.25 1 
Tetracycline 43 (61.43) 1 (1.43) 26 (37.14) 1 16 
*An intermediate: Isolate is one that is inhibited in vitro but therapeutic effect is uncertain 
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Fig. 2: MIC distribution of doxycycline (DO), tetracycline (TET) and minocycline (MN) among 
TET-R, tet(K) gene positive S. aureus (n=58) 
 
On screening the isolates for the presence of 
four commonly found tetracycline resistance 
genes, 58 (78 %) of the isolates were positive 
for tet(K). The tet(K) gene protects bacteria 
from tetracycline by a resistance mechanism 
known as tetracycline efflux. This mechanism 
prevents the accumulation of tetracycline 
within bacterial cells [1] by the synthesis of a 
cytoplasmic membrane protein which pumps 
tetracycline out of the cell at a quicker rate 
than it enters [3]. This may explain why tet(K) 
gene does not impart resistance to 
minocycline. 
Twenty four of the isolates had raised levels 
of resistance to minocycline, which was 
reflected in the MIC90 value of 64 ug/ml. The 
raised level of minocycline resistance may be 
due to other tetracycline resistance genes, 
besides tet(K) being present within the 
isolates that were not screened for.  
 
Trzcinski et al, in a study conducted in 
Poland, found 66 % tet(K) in tetracycline-
resistant MRSA [12]. Schmitz et al, in 1997 – 
99, collected 400 MRSA and 200 MSSA from 
25 university hospitals in Europe in the 
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international SENTRY program. They 
detected tet(K) in 73 % (292/400) MRSA and 
96 % (192/200) MSSA isolates [7]. Huys et 
al, in 2005, in a collection of S. aureus from 
poultry processing plants reported 58 % 
(22/38) tet(K) in South Africa [16]. The level 
of tet(K) genes present in the three studies 
provides evidence to suggest that the 
distribution of tet(K) genes in S. aureus are 
wide spread. In addition to this, the frequency 
at which tet(K) occurs signifies that in S. 
aureus, the main mechanism of resistance is 
through tetracycline efflux. This also suggests 
that when screening S. aureus for 
tetracycline resistance genes, tet(K) must 
always be screened for first. 
 
No traces of tet(O) were found in the current 
study and these findings correlate with those 
of Bismuth et al. This suggests that this gene 
is rare in S. aureus, unlike tet(K). In addition, 
there is very little evidence to indicate the 
occurrence of tet(L) in Staphylococci species, 
as indicated by both Bismuth et al and 
Trzcinski  et al. As a result, this study as qell 
as previous studies indicate that tet(K) is 
widely distributed, and therefore, is more 




The findings of this study indicate the 
mechanism of resistance to tetracyclines in 
S. aureus isolates from Pakistan could be 
through the production of efflux pumps, 
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